BC
IPCI

Broadfin Capital’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Broadfin Capital’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-175,626
Closed -$3.44M – 71
2013
Q3 		$3.44M Sell
175,626
-20,452
-10% -$402K 0.61% 40
2013
Q2 		$3.33M Buy
+196,078
New +$3.61M 0.65% 35

Other funds holding IPCI

TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Broadfin Capital's IPCI Position: Q4 2013 in Review

Broadfin Capital sold out of Intellipharmaceuticals International Inc. (IPCI) in Q4 2013, closing a stake of 175,626 shares — an estimated $3.44M sold.

Broadfin Capital first reported a position in IPCI in Q2 2013 and held it in 2 quarters. The position peaked at $3.44M in Q3 2013. 13 funds tracked by Wall St. Rank hold IPCI as of Q4 2013.

  • Broadfin Capital reported no remaining Intellipharmaceuticals International Inc. position as of Q4 2013 after selling out during the quarter.
  • Broadfin Capital sold 175,626 Intellipharmaceuticals International Inc. shares in Q4 2013, an estimated $3.44M.
  • Broadfin Capital first reported a position in Intellipharmaceuticals International Inc. in Q2 2013 and held it in 2 quarters.
  • Broadfin Capital's Intellipharmaceuticals International Inc. position peaked at $3.44M in Q3 2013.
  • 13 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q4 2013.

Based on Broadfin Capital's 13F filing for Q4 2013, filed 14 Feb 2014.